Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 6439864, 10 pages
http://dx.doi.org/10.1155/2016/6439864
Review Article

Endothelial Transdifferentiation of Tumor Cells Triggered by the Twist1-Jagged1-KLF4 Axis: Relationship between Cancer Stemness and Angiogenesis

Research Center for Tumor Medical Science, Graduate Institute of Cancer Biology, China Medical University, Taichung 404, Taiwan

Received 26 August 2015; Accepted 15 October 2015

Academic Editor: Silvia Brunelli

Copyright © 2016 Hsiao-Fan Chen and Kou-Juey Wu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. I. Bray, and S. S. Devesa, “Cancer burden in the year 2000. The global picture,” European Journal of Cancer, vol. 37, supplement 8, pp. S4–S66, 2001. View at Google Scholar
  2. A. F. Chambers, A. C. Groom, and I. C. MacDonald, “Dissemination and growth of cancer cells in metastatic sites,” Nature Reviews Cancer, vol. 2, no. 8, pp. 563–572, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. J. H. Tsai and J. Yang, “Epithelial-mesenchymal plasticity in carcinoma metastasis,” Genes and Development, vol. 27, no. 20, pp. 2192–2206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Brabletz, A. Jung, S. Spaderna, F. Hlubek, and T. Kirchner, “Migrating cancer stem cells—an integrated concept of malignant tumour progression,” Nature Reviews Cancer, vol. 5, no. 9, pp. 744–749, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M.-H. Yang, D. S.-S. Hsu, H.-W. Wang et al., “Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition,” Nature Cell Biology, vol. 12, no. 10, pp. 982–992, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Polyak and R. A. Weinberg, “Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits,” Nature Reviews Cancer, vol. 9, no. 4, pp. 265–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Singh and J. Settleman, “EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer,” Oncogene, vol. 29, no. 34, pp. 4741–4751, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Nurwidya, F. Takahashi, A. Murakami, and K. Takahashi, “Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer,” Cancer Research and Treatment, vol. 44, no. 3, pp. 151–156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Arumugam, V. Ramachandran, K. F. Fournier et al., “Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer,” Cancer Research, vol. 69, no. 14, pp. 5820–5828, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Liu, F. Du, Q. Zhao, J. Jin, X. Ma, and H. Li, “Acquisition of 5-fluorouracil resistance induces epithelial-mesenchymal transitions through the Hedgehog signaling pathway in HCT-8 colon cancer cells,” Oncology Letters, vol. 9, no. 6, pp. 2675–2679, 2015. View at Publisher · View at Google Scholar
  11. M. Klagsbrun and M. A. Moses, “Molecular angiogenesis,” Chemistry & Biology, vol. 6, no. 8, pp. R217–R224, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Carmeliet, “Angiogenesis in life, disease and medicine,” Nature, vol. 438, no. 7070, pp. 932–936, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. L. M. Sherwood, E. E. Parris, and J. Folkman, “Tumor angiogenesis: therapeutic implications,” The New England Journal of Medicine, vol. 285, no. 21, pp. 1182–1186, 1971. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Cao and R. Langer, “A review of Judah Folkman’s remarkable achievements in biomedicine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 36, pp. 13203–13205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Y. Yoo and S. M. Kwon, “Angiogenesis and its therapeutic opportunities,” Mediators of Inflammation, vol. 2013, Article ID 127170, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Ricci-Vitiani, R. Pallini, M. Biffoni et al., “Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells,” Nature, vol. 468, no. 7325, pp. 824–828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Wang, K. Chadalavada, J. Wilshire et al., “Glioblastoma stem-like cells give rise to tumour endothelium,” Nature, vol. 468, no. 7325, pp. 829–835, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. H.-F. Chen, C.-H. Huang, C.-J. Liu et al., “Twist1 induces endothelial differentiation of tumour cells through the Jagged1-KLF4 axis,” Nature Communications, vol. 5, article 4697, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Thisse, M. E. Messal, and F. Perrin-Schmitt, “The twist gene: isolation of a Drosophila zygotle gene necessary for the establishment of dorsoventral pattern,” Nucleic Acids Research, vol. 15, no. 8, pp. 3439–3453, 1987. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. N. Jan and L. Y. Jan, “Functional gene cassettes in development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 18, pp. 8305–8307, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Ansieau, A.-P. Morel, G. Hinkal, J. Bastid, and A. Puisieux, “TWISTing an embryonic transcription factor into an oncoprotein,” Oncogene, vol. 29, no. 22, pp. 3173–3184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Puisieux, S. Valsesia-Wittmann, and S. Ansieau, “A twist for survival and cancer progression,” British Journal of Cancer, vol. 94, no. 1, pp. 13–17, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. L. L. C. Marotta and K. Polyak, “Cancer stem cells: a model in the making,” Current Opinion in Genetics & Development, vol. 19, no. 1, pp. 44–50, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Klonisch, E. Wiechec, S. Hombach-Klonisch et al., “Cancer stem cell markers in common cancers—therapeutic implications,” Trends in Molecular Medicine, vol. 14, no. 10, pp. 450–460, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Zhao, Q. Bao, A. Renner et al., “Cancer stem cells and angiogenesis,” International Journal of Developmental Biology, vol. 55, no. 4-5, pp. 477–482, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Bao, Q. Wu, S. Sathornsumetee et al., “Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor,” Cancer Research, vol. 66, no. 16, pp. 7843–7848, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Folkins, Y. Shaked, S. Man et al., “Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1,” Cancer Research, vol. 69, no. 18, pp. 7243–7251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. M. Brown, “Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies,” Molecular Medicine Today, vol. 6, no. 4, pp. 157–162, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Brown and W. R. Wilson, “Exploiting tumour hypoxia in cancer treatment,” Nature Reviews Cancer, vol. 4, no. 6, pp. 437–447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. G. L. Wang and G. L. Semenza, “Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia,” The Journal of Biological Chemistry, vol. 268, no. 29, pp. 21513–21518, 1993. View at Google Scholar · View at Scopus
  31. G. L. Wang and G. L. Semenza, “Purification and characterization of hypoxia-inducible factor,” Journal of Biological Chemistry, vol. 270, no. 3, pp. 1230–1237, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. M.-H. Yang, M.-Z. Wu, S.-H. Chiou et al., “Direct regulation of TWIST by HIF-1α promotes metastasis,” Nature Cell Biology, vol. 10, no. 3, pp. 295–305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Folkman, “Angiogenesis,” Annual Review of Medicine, vol. 57, pp. 1–18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. L. C. L. van Kempen and W. P. J. Leenders, “Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology,” European Journal of Cell Biology, vol. 85, no. 2, pp. 61–68, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. J. A. Forsythe, B.-H. Jiang, N. V. Iyer et al., “Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1,” Molecular and Cellular Biology, vol. 16, no. 9, pp. 4604–4613, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. B. D. Kelly, S. F. Hackett, K. Hirota et al., “Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor1,” Circulation Research, vol. 93, no. 11, pp. 1074–1081, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. D. J. Ceradini, A. R. Kulkarni, M. J. Callaghan et al., “Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1,” Nature Medicine, vol. 10, no. 8, pp. 858–864, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. D. J. Manalo, A. Rowan, T. Lavoie et al., “Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1,” Blood, vol. 105, no. 2, pp. 659–669, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Bosch-Marce, H. Okuyama, J. B. Wesley et al., “Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia,” Circulation Research, vol. 101, no. 12, pp. 1310–1318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M.-P. Simon, R. Tournaire, and J. Pouyssegur, “The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1,” Journal of Cellular Physiology, vol. 217, no. 3, pp. 809–818, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Rey and G. L. Semenza, “Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling,” Cardiovascular Research, vol. 86, no. 2, pp. 236–242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. Y.-F. Dong, D. Y. Soung, Y. Chang et al., “Transforming growth factor-β and Wnt signals regulate chondrocyte differentiation through Twist1 in a stage-specific manner,” Molecular Endocrinology, vol. 21, no. 11, pp. 2805–2820, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. S. A. Mani, W. Guo, M.-J. Liao et al., “The epithelial-mesenchymal transition generates cells with properties of stem cells,” Cell, vol. 133, no. 4, pp. 704–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Mironchik, P. T. Winnard Jr., F. Vesuna et al., “Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer,” Cancer Research, vol. 65, no. 23, pp. 10801–10809, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Xi, L. Zhang, Z. Zhan et al., “The effect of twist expression on angiogenesis in hepatocellular carcinoma,” Chinese Journal of Clinical Oncology, vol. 3, no. 6, pp. 413–418, 2006. View at Publisher · View at Google Scholar
  46. I. Greenwald, “LIN-12/Notch signaling: lessons from worms and flies,” Genes and Development, vol. 12, no. 12, pp. 1751–1762, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Artavanis-Tsakonas, M. D. Rand, and R. J. Lake, “Notch signaling: cell fate control and signal integration in development,” Science, vol. 284, no. 5415, pp. 770–776, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. S. J. Bray, “Notch signalling: a simple pathway becomes complex,” Nature Reviews Molecular Cell Biology, vol. 7, no. 9, pp. 678–689, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Zavadil, L. Cermak, N. Soto-Nieves, and E. P. Böttinger, “Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition,” The EMBO Journal, vol. 23, no. 5, pp. 1155–1165, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Sahlgren, M. V. Gustafsson, S. Jin, L. Poellinger, and U. Lendahl, “Notch signaling mediates hypoxia-induced tumor cell migration and invasion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 17, pp. 6392–6397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Noseda, G. McLean, K. Niessen et al., “Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation,” Circulation Research, vol. 94, no. 7, pp. 910–917, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. Z. Wang, Y. Li, D. Kong, and F. H. Sarkar, “The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness,” Current Drug Targets, vol. 11, no. 6, pp. 745–751, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. L. T. Krebs, Y. Xue, C. R. Norton et al., “Notch signaling is essential for vascular morphogenesis in mice,” Genes and Development, vol. 14, no. 11, pp. 1343–1352, 2000. View at Google Scholar · View at Scopus
  54. N. W. Gale, M. G. Dominguez, I. Noguera et al., “Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 45, pp. 15949–15954, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Xue, X. Gao, C. E. Lindsell et al., “Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1,” Human Molecular Genetics, vol. 8, no. 5, pp. 723–730, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Mailhos, U. Modlich, J. Lewis, A. Harris, R. Bicknell, and D. Ish-Horowicz, “Delta4, an endothelial specific Notch ligand expressed at sites of physiological and tumor angiogenesis,” Differentiation, vol. 69, no. 2-3, pp. 135–144, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. N. S. Patel, J.-L. Li, D. Generali, R. Poulsom, D. W. Cranston, and A. L. Harris, “Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function,” Cancer Research, vol. 65, no. 19, pp. 8690–8697, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Thurston, I. Noguera-Troise, and G. D. Yancopoulos, “The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth,” Nature Reviews Cancer, vol. 7, no. 5, pp. 327–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Dufraine, Y. Funahashi, and J. Kitajewski, “Notch signaling regulates tumor angiogenesis by diverse mechanisms,” Oncogene, vol. 27, no. 38, pp. 5132–5137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Yin, O. C. Velazquez, and Z.-J. Liu, “Notch signaling: emerging molecular targets for cancer therapy,” Biochemical Pharmacology, vol. 80, no. 5, pp. 690–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. J.-L. Li and A. L. Harris, “Notch signaling from tumor cells: a new mechanism of angiogenesis,” Cancer Cell, vol. 8, no. 1, pp. 1–3, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. Q. Zeng, S. Li, D. B. Chepeha et al., “Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling,” Cancer Cell, vol. 8, no. 1, pp. 13–23, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Turner and M. Crossley, “Mammalian Kruppel-like transcription factors: more than just a pretty finger,” Trends in Biochemical Sciences, vol. 24, no. 6, pp. 236–240, 1999. View at Publisher · View at Google Scholar · View at Scopus
  64. D. T. Dang, J. Pevsner, and V. W. Yang, “The biology of the mammalian Krüppel-like family of transcription factors,” The International Journal of Biochemistry & Cell Biology, vol. 32, no. 11-12, pp. 1103–1121, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Kaczynski, T. Cook, and R. Urrutia, “Sp1- and Krüppel-like transcription factors,” Genome Biology, vol. 4, no. 2, article 206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. J. M. Shields, R. J. Christy, and V. W. Yang, “Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest,” The Journal of Biological Chemistry, vol. 271, no. 33, pp. 20009–20017, 1996. View at Publisher · View at Google Scholar · View at Scopus
  67. L. A. Garrett-Sinha, H. Eberspaecher, M. F. Seldin, and B. de Crombrugghef, “A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells,” Journal of Biological Chemistry, vol. 271, no. 49, pp. 31384–31390, 1996. View at Publisher · View at Google Scholar · View at Scopus
  68. M.-P. Tetreault, Y. Yang, and J. P. Katz, “Krüppel-like factors in cancer,” Nature Reviews Cancer, vol. 13, no. 10, pp. 701–713, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. J. L. Yori, E. Johnson, G. Zhou, M. K. Jain, and R. A. Keri, “Krüppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression,” The Journal of Biological Chemistry, vol. 285, no. 22, pp. 16854–16863, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. H. K. Lee, D. S. Lee, and J. C. Park, “Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer,” BMC Cancer, vol. 15, article 113, 2015. View at Publisher · View at Google Scholar
  71. N. Tiwari, N. Meyer-Schaller, P. Arnold et al., “Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8),” PLoS ONE, vol. 8, no. 2, Article ID e57329, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. J. L. Yori, D. D. Seachrist, E. Johnson et al., “Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer,” Neoplasia, vol. 13, no. 7, pp. 601–610, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. B. B. McConnell, A. M. Ghaleb, M. O. Nandan, and V. W. Yang, “The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology,” BioEssays, vol. 29, no. 6, pp. 549–557, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. B. D. Rowland and D. S. Peeper, “KLF4, p21 and context-dependent opposing forces in cancer,” Nature Reviews Cancer, vol. 6, no. 1, pp. 11–23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. K. W. Foster, A. R. Frost, P. McKie-Bell et al., “Increase of GKLF messenger RNA and protein expression during progression of breast cancer,” Cancer Research, vol. 60, no. 22, pp. 6488–6495, 2000. View at Google Scholar · View at Scopus
  76. D. S. Grant, K.-I. Tashiro, B. Segui-Real, Y. Yamada, G. R. Martin, and H. K. Kleinman, “Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro,” Cell, vol. 58, no. 5, pp. 933–943, 1989. View at Publisher · View at Google Scholar · View at Scopus
  77. K. W. Foster, Z. Liu, C. D. Nail et al., “Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia,” Oncogene, vol. 24, no. 9, pp. 1491–1500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. N. B. Prasad, A. V. Biankin, N. Fukushima et al., “Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells,” Cancer Research, vol. 65, no. 5, pp. 1619–1626, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. J. P. Kirton, P. Campagnolo, E. Di Bernardini, and Q. Xu, “Klf4 acts as a molecular switch during stem cell differentiation into endothelial and smooth muscle cells,” Circulation, vol. 122, no. 21, p. A15048, 2010. View at Google Scholar
  81. C. E. Cowan, E. E. Kohler, T. A. Dugan, M. K. Mirza, A. B. Malik, and K. K. Wary, “Krüppel-like factor-4 transcriptionally regulates VE-cadherin expression and endothelial barrier function,” Circulation Research, vol. 107, no. 8, pp. 959–966, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. S. M. Garvey, D. S. Sinden, P. D. Schoppee Bortz, and B. R. Wamhoff, “Cyclosporine up-regulates Krüppel-like factor-4 (KLF4) in vascular smooth muscle cells and drives phenotypic modulation in vivo,” Journal of Pharmacology and Experimental Therapeutics, vol. 333, no. 1, pp. 34–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. A. T. Hale, H. Tian, E. Anih et al., “Endothelial Krüppel-like factor 4 regulates angiogenesis and the Notch signaling pathway,” The Journal of Biological Chemistry, vol. 289, no. 17, pp. 12016–12028, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. L. Liu and G.-P. Shi, “CD31: beyond a marker for endothelial cells,” Cardiovascular Research, vol. 94, no. 1, pp. 3–5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. D. Vestweber, “VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 2, pp. 223–232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. L. Zanetta, S. G. Marcus, J. Vasile et al., “Expression of von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis,” International Journal of Cancer, vol. 85, no. 2, pp. 281–288, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Anghelina, L. Moldovan, and N. I. Moldovan, “Preferential activity of Tie2 promoter in arteriolar endothelium,” Journal of Cellular and Molecular Medicine, vol. 9, no. 1, pp. 113–121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. E. Fonsatti, M. Altomonte, M. R. Nicotra, P. G. Natali, and M. Maio, “Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels,” Oncogene, vol. 22, no. 42, pp. 6557–6563, 2003. View at Publisher · View at Google Scholar · View at Scopus
  89. V. Videm and M. Albrigtsen, “Soluble ICAM-1 and VCAM-1 as markers of endothelial activation,” Scandinavian Journal of Immunology, vol. 67, no. 5, pp. 523–531, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. I. Arnaoutova and H. K. Kleinman, “In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract,” Nature Protocols, vol. 5, no. 4, pp. 628–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. Y. Okaji, N. H. Tsuno, J. Kitayama et al., “A novel method for isolation of endothelial cells and macrophages from murine tumors based on Ac-LDL uptake and CD16 expression,” Journal of Immunological Methods, vol. 295, no. 1-2, pp. 183–193, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. S. M. Weis and D. A. Cheresh, “Tumor angiogenesis: molecular pathways and therapeutic targets,” Nature Medicine, vol. 17, no. 11, pp. 1359–1370, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. T. Sun, N. Zhao, X.-L. Zhao et al., “Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry,” Hepatology, vol. 51, no. 2, pp. 545–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. H.-Y. Yen, M.-C. Ting, and R. E. Maxson, “Jagged1 functions downstream of Twist1 in the specification of the coronal suture and the formation of a boundary between osteogenic and non-osteogenic cells,” Developmental Biology, vol. 347, no. 2, pp. 258–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. K.-W. Hsu, R.-H. Hsieh, K.-H. Huang et al., “Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression,” Carcinogenesis, vol. 33, no. 8, pp. 1459–1467, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. G. Farnie and R. B. Clarke, “Mammary stem cells and breast cancer—role of Notch signalling,” Stem Cell Reviews, vol. 3, no. 2, pp. 169–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. V. Bolós, M. Blanco, V. Medina, G. Aparicio, S. Díaz-Prado, and E. Grande, “Notch signalling in cancer stem cells,” Clinical and Translational Oncology, vol. 11, no. 1, pp. 11–19, 2009. View at Publisher · View at Google Scholar
  98. A. Pannuti, K. Foreman, P. Rizzo et al., “Targeting Notch to target cancer stem cells,” Clinical Cancer Research, vol. 16, no. 12, pp. 3141–3152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. V. L. Bautch, “Tumour stem cells switch sides,” Nature, vol. 468, no. 7325, pp. 770–771, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. A. K. K. Teo, S. J. Arnold, M. W. B. Trotter et al., “Pluripotency factors regulate definitive endoderm specification through eomesodermin,” Genes & Development, vol. 25, no. 3, pp. 238–250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Bardelli and P. A. Jänne, “The road to resistance: EGFR mutation and cetuximab,” Nature Medicine, vol. 18, no. 2, pp. 199–200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Merlano and M. Occelli, “Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck,” Therapeutics and Clinical Risk Management, vol. 3, no. 5, pp. 871–876, 2007. View at Google Scholar · View at Scopus
  103. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Publisher · View at Google Scholar · View at Scopus
  104. G. Bergers and D. Hanahan, “Modes of resistance to anti-angiogenic therapy,” Nature Reviews Cancer, vol. 8, no. 8, pp. 592–603, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. F. Panza, V. Frisardi, B. P. Imbimbo et al., “γ-secretase inhibitors for the treatment of Alzheimer’s disease: the current state,” CNS Neuroscience & Therapeutics, vol. 16, no. 5, pp. 272–284, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. A. R. Hallahan, J. I. Pritchard, S. Hansen et al., “The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas,” Cancer Research, vol. 64, no. 21, pp. 7794–7800, 2004. View at Publisher · View at Google Scholar · View at Scopus
  107. J. O’Neil, J. Calvo, K. McKenna et al., “Activating Notch1 mutations in mouse models of T-ALL,” Blood, vol. 107, no. 2, pp. 781–785, 2006. View at Publisher · View at Google Scholar · View at Scopus
  108. B. J. Nickoloff, B. A. Osborne, and L. Miele, “Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents,” Oncogene, vol. 22, no. 43, pp. 6598–6608, 2003. View at Publisher · View at Google Scholar · View at Scopus
  109. I. Krop, T. Demuth, T. Guthrie et al., “Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors,” Journal of Clinical Oncology, vol. 30, no. 19, pp. 2307–2313, 2012. View at Publisher · View at Google Scholar · View at Scopus